vs

Side-by-side financial comparison of AbbVie (ABBV) and Cisco (CSCO). Click either name above to swap in a different company.

AbbVie is the larger business by last-quarter revenue ($16.6B vs $15.3B, roughly 1.1× Cisco). Cisco runs the higher net margin — 20.7% vs 10.9%, a 9.8% gap on every dollar of revenue. On growth, AbbVie posted the faster year-over-year revenue change (10.0% vs 9.7%). AbbVie produced more free cash flow last quarter ($4.9B vs $1.5B). Over the past eight quarters, AbbVie's revenue compounded faster (16.2% CAGR vs 9.9%).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

Cisco Systems, Inc. is an American multinational digital communications technology conglomerate corporation headquartered in San Jose, California. Cisco develops, manufactures, and sells networking hardware, software, telecommunications equipment and other high-technology services and products.

ABBV vs CSCO — Head-to-Head

Bigger by revenue
ABBV
ABBV
1.1× larger
ABBV
$16.6B
$15.3B
CSCO
Growing faster (revenue YoY)
ABBV
ABBV
+0.3% gap
ABBV
10.0%
9.7%
CSCO
Higher net margin
CSCO
CSCO
9.8% more per $
CSCO
20.7%
10.9%
ABBV
More free cash flow
ABBV
ABBV
$3.4B more FCF
ABBV
$4.9B
$1.5B
CSCO
Faster 2-yr revenue CAGR
ABBV
ABBV
Annualised
ABBV
16.2%
9.9%
CSCO

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ABBV
ABBV
CSCO
CSCO
Revenue
$16.6B
$15.3B
Net Profit
$1.8B
$3.2B
Gross Margin
72.6%
65.0%
Operating Margin
27.3%
24.6%
Net Margin
10.9%
20.7%
Revenue YoY
10.0%
9.7%
Net Profit YoY
8354.5%
30.8%
EPS (diluted)
$1.02
$0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABBV
ABBV
CSCO
CSCO
Q1 26
$15.3B
Q4 25
$16.6B
$14.9B
Q3 25
$15.8B
$14.7B
Q2 25
$15.4B
$14.1B
Q1 25
$13.3B
$14.0B
Q4 24
$15.1B
$13.8B
Q3 24
$14.5B
$13.6B
Q2 24
$14.5B
$12.7B
Net Profit
ABBV
ABBV
CSCO
CSCO
Q1 26
$3.2B
Q4 25
$1.8B
$2.9B
Q3 25
$186.0M
$2.5B
Q2 25
$938.0M
$2.5B
Q1 25
$1.3B
$2.4B
Q4 24
$-22.0M
$2.7B
Q3 24
$1.6B
$2.2B
Q2 24
$1.4B
$1.9B
Gross Margin
ABBV
ABBV
CSCO
CSCO
Q1 26
65.0%
Q4 25
72.6%
65.5%
Q3 25
66.4%
63.2%
Q2 25
71.8%
65.6%
Q1 25
70.0%
65.1%
Q4 24
70.9%
65.9%
Q3 24
70.9%
64.4%
Q2 24
70.9%
65.1%
Operating Margin
ABBV
ABBV
CSCO
CSCO
Q1 26
24.6%
Q4 25
27.3%
22.6%
Q3 25
12.1%
21.0%
Q2 25
31.7%
22.6%
Q1 25
28.0%
22.3%
Q4 24
-9.9%
17.0%
Q3 24
26.5%
19.2%
Q2 24
27.6%
17.2%
Net Margin
ABBV
ABBV
CSCO
CSCO
Q1 26
20.7%
Q4 25
10.9%
19.2%
Q3 25
1.2%
17.4%
Q2 25
6.1%
17.6%
Q1 25
9.6%
17.4%
Q4 24
-0.1%
19.6%
Q3 24
10.8%
15.8%
Q2 24
9.5%
14.8%
EPS (diluted)
ABBV
ABBV
CSCO
CSCO
Q1 26
$0.80
Q4 25
$1.02
$0.72
Q3 25
$0.10
$0.64
Q2 25
$0.52
$0.62
Q1 25
$0.72
$0.61
Q4 24
$-0.03
$0.68
Q3 24
$0.88
$0.54
Q2 24
$0.77
$0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABBV
ABBV
CSCO
CSCO
Cash + ST InvestmentsLiquidity on hand
$5.3B
$15.8B
Total DebtLower is stronger
$58.9B
$24.6B
Stockholders' EquityBook value
$-3.3B
$47.7B
Total Assets
$134.0B
$123.4B
Debt / EquityLower = less leverage
0.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABBV
ABBV
CSCO
CSCO
Q1 26
$15.8B
Q4 25
$5.3B
$15.7B
Q3 25
$5.7B
$16.1B
Q2 25
$6.5B
$15.6B
Q1 25
$5.2B
$16.9B
Q4 24
$5.6B
$18.7B
Q3 24
$7.3B
$17.9B
Q2 24
$13.2B
$18.8B
Total Debt
ABBV
ABBV
CSCO
CSCO
Q1 26
$24.6B
Q4 25
$58.9B
$24.6B
Q3 25
$63.0B
$24.6B
Q2 25
$63.0B
$25.1B
Q1 25
$64.5B
$20.1B
Q4 24
$60.3B
$20.1B
Q3 24
$58.5B
$20.1B
Q2 24
$58.0B
$20.1B
Stockholders' Equity
ABBV
ABBV
CSCO
CSCO
Q1 26
$47.7B
Q4 25
$-3.3B
$46.9B
Q3 25
$-2.6B
$46.8B
Q2 25
$-183.0M
$45.9B
Q1 25
$1.4B
$45.5B
Q4 24
$3.3B
$45.3B
Q3 24
$6.0B
$45.5B
Q2 24
$6.8B
$45.8B
Total Assets
ABBV
ABBV
CSCO
CSCO
Q1 26
$123.4B
Q4 25
$134.0B
$121.1B
Q3 25
$133.9B
$122.3B
Q2 25
$137.2B
$119.8B
Q1 25
$136.2B
$121.4B
Q4 24
$135.2B
$123.3B
Q3 24
$143.4B
$124.4B
Q2 24
$141.9B
$123.0B
Debt / Equity
ABBV
ABBV
CSCO
CSCO
Q1 26
0.52×
Q4 25
0.53×
Q3 25
0.53×
Q2 25
0.55×
Q1 25
45.44×
0.44×
Q4 24
18.15×
0.44×
Q3 24
9.70×
0.44×
Q2 24
8.56×
0.44×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABBV
ABBV
CSCO
CSCO
Operating Cash FlowLast quarter
$5.2B
$1.8B
Free Cash FlowOCF − Capex
$4.9B
$1.5B
FCF MarginFCF / Revenue
29.4%
10.0%
Capex IntensityCapex / Revenue
2.0%
1.8%
Cash ConversionOCF / Net Profit
2.87×
0.57×
TTM Free Cash FlowTrailing 4 quarters
$17.8B
$12.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABBV
ABBV
CSCO
CSCO
Q1 26
$1.8B
Q4 25
$5.2B
$3.2B
Q3 25
$7.0B
$4.2B
Q2 25
$5.2B
$4.1B
Q1 25
$1.6B
$2.2B
Q4 24
$7.0B
$3.7B
Q3 24
$5.4B
$3.7B
Q2 24
$2.3B
$4.0B
Free Cash Flow
ABBV
ABBV
CSCO
CSCO
Q1 26
$1.5B
Q4 25
$4.9B
$2.9B
Q3 25
$6.6B
$4.0B
Q2 25
$4.9B
$3.8B
Q1 25
$1.4B
$2.0B
Q4 24
$6.8B
$3.4B
Q3 24
$5.2B
$3.5B
Q2 24
$2.0B
$3.8B
FCF Margin
ABBV
ABBV
CSCO
CSCO
Q1 26
10.0%
Q4 25
29.4%
19.4%
Q3 25
42.1%
27.4%
Q2 25
31.7%
26.8%
Q1 25
10.5%
14.5%
Q4 24
44.7%
24.9%
Q3 24
35.9%
25.9%
Q2 24
14.0%
29.9%
Capex Intensity
ABBV
ABBV
CSCO
CSCO
Q1 26
1.8%
Q4 25
2.0%
2.2%
Q3 25
2.4%
1.5%
Q2 25
1.7%
1.8%
Q1 25
1.8%
1.5%
Q4 24
1.9%
1.6%
Q3 24
1.7%
1.5%
Q2 24
1.7%
1.3%
Cash Conversion
ABBV
ABBV
CSCO
CSCO
Q1 26
0.57×
Q4 25
2.87×
1.12×
Q3 25
37.76×
1.66×
Q2 25
5.49×
1.63×
Q1 25
1.27×
0.92×
Q4 24
1.35×
Q3 24
3.49×
1.73×
Q2 24
1.66×
2.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABBV
ABBV

Segment breakdown not available.

CSCO
CSCO

Networking$8.3B54%
Services$3.7B24%
Security$2.0B13%
Collaboration$1.1B7%
Observability$277.0M2%

Related Comparisons